Evidence map›Paper›PMID 39506854›Full record

ArticleBiological research2024

GLUT1 and prorenin receptor mediate differential regulation of TGF-β and CTGF in renal inner medullary collecting duct cells during high glucose conditions.

Paulina E Larenas, Pilar Cárdenas, Monserrat Aguirre-Delgadillo, Carlos Moris, Dulce E Casarini, Zoe Vallotton, Minolfa C Prieto, Alexis A Gonzalez

Abstract read
In one paragraph

Article in Biological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paulina E Larenas *Instituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Pilar Cárdenas *Instituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Monserrat Aguirre-DelgadilloInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Carlos MorisInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Dulce E CasariniDepartamento de Medicina, Disciplina de Nefrología, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Zoe VallottonDepartment of Physiology and Tulane Hypertension and Renal Center of Excellence, Tulane University School of Medicine, New Orleans, LA, USA.
Minolfa C PrietoDepartment of Physiology and Tulane Hypertension and Renal Center of Excellence, Tulane University School of Medicine, New Orleans, LA, USA.
Alexis A GonzalezInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile. alexis.gonzalez@pucv.cl.ORCID http://orcid.org/0000-0003-0323-1448

Funding

COVID-19 and Kidney Injury: Urinary Transcriptomics of Kidney Injury in Novel Nonhuman Primate Models of SARS-CoV-2R21AI164232 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI PRIETO, MINOLFA C · 2022 to 2023
$433k
Fondo Nacional de Desarrollo Científico y Tecnológico 1220525Foundation for the National Institutes of Health R21AI164232Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2017/17027-0NIAID NIH HHS R21 AI164232
6 · The paper itself

Abstract

backgroundDuring diabetes, prorenin is highly produced by the renal collecting ducts. The binding of prorenin to (pro)renin receptor (PRR) on the apical plasma membrane triggers intracellular profibrotic genes, including TGF-β and CTGF. However, the underlying mechanisms contributing to the stimulation of these pathways remain unclear. Hence, we hypothesize that the glucose transporter-1 (GLUT1) favors the PRR-dependent stimulation of TGF-β and CTGF in the distal nephron segments during high glucose (HG) conditions.

methodsTo test this hypothesis, primary cultured renal inner medullary collecting duct (IMCD) cells were treated with normal glucose (NG, 5 mM) or high glucose (HG, 25 mM) for 48 h in the presence or absence of the GLUT1-specific inhibitor BAY 876 (2 nM). Additionally, IMCD cells were treated with the PRR antagonist PRO20. The expression of TGF-β and CTGF was quantified by immunoblot and qRT-PCR.

resultsHG increased GLUT1 mRNA and protein abundance, while BAY 876 inhibited these responses. HG treatment upregulated PRR, but the concomitant treatment with BAY 876 partially prevented this effect. TGF-β and CTGF expressions were augmented in IMCD cells treated with HG. However, PRO20 prevented the increases in TGF-β but not those of CTGF. GLUT1 inhibition partially prevented the increases in reactive oxygen species (ROS) during HG while PRO20 did not. ROS scavenging impaired CTGF upregulation during HG conditions. Additionally, long-term exposure to HG increases lipid peroxidation and reduced cell viability.

conclusionsThe data indicate that glucose transportation via GLUT1 is implicated in the PRR-dependent upregulation of TGF-β while CTGF is mediated mainly via a mechanism depending on ROS formation in renal medullary collecting duct cells.

Indexed as

Connective Tissue Growth FactorGlucoseGlucose Transporter Type 1Kidney Tubules, CollectingProrenin ReceptorReceptors, Cell SurfaceTransforming Growth Factor betaAnimalsCells, CulturedMaleRatsRats, Sprague-DawleyReactive Oxygen SpeciesConnective Tissue Growth FactorGlucoseGlucose Transporter Type 1Prorenin ReceptorReactive Oxygen SpeciesReceptors, Cell SurfaceTransforming Growth Factor betaDiabetesHigh glucoseKidneyProreninRenal fibrosis

Identifiers

PMID39506854
PMCPMC11542404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.